Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PAVmed (PAVM) Current Assets (2021 - 2025)

PAVmed has reported Current Assets over the past 5 years, most recently at $2.6 million for Q4 2025.

  • Quarterly results put Current Assets at $2.6 million for Q4 2025, up 18.16% from a year ago — trailing twelve months through Dec 2025 was $2.6 million (up 18.16% YoY), and the annual figure for FY2025 was $2.6 million, up 18.16%.
  • Current Assets for Q4 2025 was $2.6 million at PAVmed, down from $4.2 million in the prior quarter.
  • Over the last five years, Current Assets for PAVM hit a ceiling of $82.6 million in Q4 2021 and a floor of $2.2 million in Q4 2024.
  • Median Current Assets over the past 5 years was $37.1 million (2021), compared with a mean of $36.0 million.
  • Biggest five-year swings in Current Assets: soared 52.83% in 2022 and later crashed 91.17% in 2024.
  • PAVmed's Current Assets stood at $82.6 million in 2021, then plummeted by 46.84% to $43.9 million in 2022, then plummeted by 44.23% to $24.5 million in 2023, then crashed by 91.17% to $2.2 million in 2024, then increased by 18.16% to $2.6 million in 2025.
  • The last three reported values for Current Assets were $2.6 million (Q4 2025), $4.2 million (Q3 2025), and $5.5 million (Q2 2025) per Business Quant data.